Old Web
English
Sign In
Acemap
>
Paper
>
542P Growth modulation index (GMI) of larotrectinib versus prior systemic treatments for TRK fusion cancer patients
542P Growth modulation index (GMI) of larotrectinib versus prior systemic treatments for TRK fusion cancer patients
2020
Antoine Italiano
David S. Hong
Andrew Briggs
Jesús García-Foncillas
Ulrik Lassen
Gilles Vassal
Shivaani Kummar
C.M. van Tilburg
Karen N. Keating
John A. Reeves
Marc Mardoche Fellous
H. Nogai
Theodore W. Laetsch
A. Drilon
Keywords:
Trk receptor
Oncology
Cancer
Internal medicine
Medicine
Modulation index
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI
[]
map